Patent · US Active

Hematopoietic growth factor mimetic small molecule compounds and their uses

US9144557B2 · kind B2 · utility

3Cited by

3References

21Claims

0Family size

Assignee

Ligand Pharmaceuticals Incorporated · US

Inventors

Lin Zhi · San Diego, US
Andrew R. Hudson · San Diego, US
Cornelis Arjan Van Oeveren · Carlsbad, US
Steven L. Roach · San Diego, US
Bijan Pedram · San Diego, US
Yixing Shen · Encinitas, US
Lino Valdez · Carlsbad, US
Jillian Basinger · San Diego, US
Virginia Heather Sharron Grant · San Diego, US
Jason C. Pickens · San Diego, US

Key dates

Filing date	Oct 12, 2010
Grant date	Sep 29, 2015
Priority date	—
Expiry date	Dec 3, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D491/113
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present embodiments relate to compounds with physiological effects, such as the activation of hematopoietic growth factor receptors. The present embodiments also relate to use of the compounds to treat a variety of conditions, diseases and ailments such as hematopoietic conditions and disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.